about
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetinePreclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial designInteractions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptorDesipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neuronsFluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell LinesNew insights into the intracellular distribution pattern of cationic amphiphilic drugs.Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells.The role of imaging in proof of concept for CNS drug discovery and development.Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.Fluorine (19F) MRS and MRI in biomedicine.Therapeutic potential of fluoxetine in neurological disorders.Block by fluoxetine of volume-regulated anion channels.Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivityInhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetineInhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).Fluoxetine regulates neurogenesis in vitro through modulation of GSK-3β/β-catenin signalingCellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats.Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis.MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.Fluoxetine impairs GABAergic signaling in hippocampal slices from neonatal rats.Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.Effect of amitriptyline on tetrodotoxin-resistant Nav1.9 currents in nociceptive trigeminal neurons.Effects of analgesics and antidepressants on TREK-2 and TRESK currentsRationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis.Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.The role of ceramide in major depressive disorder.Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition.Direct inhibition of retinoic acid catabolism by fluoxetine.Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.Antidepressant fluoxetine suppresses neuronal growth from both vertebrate and invertebrate neurons and perturbs synapse formation between Lymnaea neurons.Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants.Fluoxetine attenuates the inhibitory effect of glucocorticoid hormones on neurogenesis in vitro via a two-pore domain potassium channel, TREK-1.Inhibition of hippocampal excitability by citalopram.Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain.Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study.Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes.
P2860
Q24670560-356978A7-418A-4CF8-B8B6-A172C1821032Q26850811-35CBD61B-5F18-4D6D-A9CC-176B71BF750FQ28293888-48EDEC1B-951F-4C29-83DD-3517CEAC0514Q28485344-2E473857-A602-44E1-9FC0-A83756DD07EFQ28554574-E2563FC1-A578-43CB-B976-CD4A47379047Q30841407-68F0ECDA-AB3A-401C-9488-900F129A118DQ33349223-93DDE029-F70A-4B93-A603-977A14A81D4AQ33374793-CBEFF8D9-1D3D-41A9-9487-D989A6093A2DQ34099069-2CC0F998-CE51-42D6-A935-DE48E1D5025DQ34540452-9F5A5685-CA5F-42B6-A871-B00A802481A5Q34635770-69967579-CFEE-4AD5-AC2F-246ED404D7FCQ34778793-4E07815D-CFB7-4498-B600-EBEECCB04AF2Q35028429-F4D0A801-63B7-4326-9430-13FFD250EEE9Q35028911-55651396-4AB3-4AFC-9701-DDF662A3C118Q35041767-DF0B171F-ADB9-46D1-B58D-AB73EA9DD2D4Q35045125-020F3380-C241-46F7-9C58-4F1B4A2E9FA8Q35224304-B2E15168-A462-40E2-B986-671BE17A1F7DQ35636279-080E27C2-263B-4231-8A7F-4A1C3EC08E10Q35741615-E7363C6C-8882-4B8C-9D21-10969FE5C5CFQ36598509-4263DC11-8272-4274-8684-7C73B34C229DQ36806023-FD301AF3-C6A7-4727-807C-BF403EFC1C74Q36906632-475FE36E-7E87-4A62-8E62-38E5582F91D9Q36953269-978C58B7-AEC1-4E1A-BBCA-87B89EC9ACD9Q37060285-E3CAEE6F-2B5F-4FDD-84CE-CFACCD2ECF93Q37378440-24306AB9-9C51-4D5F-BC42-3D6CFE97D302Q37597918-00371D37-4367-440D-8BF2-00976FFFE383Q37624460-4F125853-E0B8-49F4-BA48-882A1677E94AQ38704329-4BF79365-4809-48E8-9CC9-D27AF4104BF1Q38874017-AB0E43BF-A3A8-4178-9817-C914FCC0C7D9Q39218780-4BE1FAD0-A97C-4FA7-9629-3E7EFC28267CQ39717209-481578CC-3F7E-4C16-949F-8C96931CAF24Q40971013-4251C02E-D9DE-4B98-A9C7-AE6BD77D1E0CQ42682344-92DB9F79-7BCB-405D-8E86-F6FDD8AE9DA1Q42822200-EB6C4554-9554-4238-B433-8549579EACA3Q43647176-69ACAF08-E47C-4878-8E81-BDAF50987717Q43691281-F2A01B9E-7E36-4FDE-B7E6-426B0182AFF5Q45049140-06EDD3BE-A692-4ED9-B2D2-FC6301F33785Q48182924-A8953BB7-2A9E-483F-AF37-E7CEC527BEBFQ48273341-4ADD35DB-E7F4-465B-93DE-A4C0439916A4Q48349727-40E24D20-D69C-444F-A842-A9570BB3AF0D
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Human brain fluoxetine concentrations.
@en
Human brain fluoxetine concentrations.
@nl
type
label
Human brain fluoxetine concentrations.
@en
Human brain fluoxetine concentrations.
@nl
prefLabel
Human brain fluoxetine concentrations.
@en
Human brain fluoxetine concentrations.
@nl
P2093
P356
P1476
Human brain fluoxetine concentrations.
@en
P2093
Komoroski RA
Livingston R
P304
P356
10.1176/JNP.5.3.322
P577
1993-01-01T00:00:00Z